Share 0
Share 0
Post 0

Doravirine works as well as dolutegravir to suppress HIV viral load, study finds

Monday, August 3rd, 2026

If you’re a Black, 34-year-old South African woman living with HIV, antiretroviral (ARV) treatment options have likely been limited to tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and the “gold standard,” dolutegravir (DTG). Now, another once-daily, three-drug regimen has been found to be as effective as DTG in suppressing HIV viral load.

WE WANT YOU!

are you a developer?

  • Proven International Track Record
  • Vertically Integrated Federal Funds
  • Vertically Integrated Tax Credits
  • Vertically Integrated Investors
  • Vertically Integrated Lenders
  • Vertically Integrated Contractors
 List your project

Report

Contains abusive or threatening content.
There has been a breach of confidentiality.
There has been a breach of contract.
There has been a breach of fiduciary within a partnership.
Contains mature, sensitive, or otherwise inappropriate content.
Contains misleading or false information with perceived intent.
Harassment or otherwise unwanted, unprofessional, or excessive communication or attempted communication.
Contains spam, potential malware, or otherwise not generally professional content.

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .